Vasodilator drugs in peripheral vascular disease

Area of Science:

• Pharmacology
• Vascular Medicine
• Medical Therapeutics

Background:

• Peripheral vascular disease (PVD) encompasses conditions affecting blood circulation outside the brain and heart.
• Vasodilator drugs aim to widen blood vessels, potentially improving blood flow.
• The efficacy of various vasodilators in PVD remains a subject of clinical interest.

Purpose of the Study:

• To review the actions and efficacy of different classes of vasodilator drugs used in peripheral vascular disease.
• To evaluate the evidence supporting the use of vasodilators in obstructive and vasospastic arterial conditions.

Main Methods:

• Literature review of animal and clinical studies on vasodilator drug effectiveness.
• Categorization of drugs based on their mechanism of action: direct-acting, beta-receptor stimulating, and sympathetic nervous system affecting agents.

Main Results:

• Little evidence supports the effectiveness of vasodilator drugs for obstructive arterial disease.
• Some vasodilators acting on the sympathetic nervous system may offer benefits in vasospastic diseases.
• Specific drugs reviewed include isoxsuprine, papaverine, niacin, cyclandelate, nylidrin, tolazoline, reserpine, guanethidine, methyldopa, ergot alkaloids, and alcohol.

Conclusions:

• Current evidence suggests limited utility of most vasodilators in treating obstructive arterial disease.
• Vasodilators targeting the sympathetic nervous system may provide symptomatic relief in specific vasospastic conditions by enhancing capillary blood flow.